FN
Ferzaan Nariman Engineer
About Ferzaan Nariman Engineer
Data last updated:
Ferzaan Nariman Engineer is a Director at Cytecare Hospitals Private Limited (since 2014), Director at Cytespace Research Private Limited (since 2014) and Director at Emergene Ai Private Limited (since 2026), and holds 1 more current directorship. The companies operate in Healthcare, Pharma and Consumer Services. The 2 current companies with reported revenue have a combined latest revenue of ₹94.03 Cr; the largest is Cytecare Hospitals Private Limited at ₹93.10 Cr (FY 2024). Earlier, Ferzaan Nariman Engineer was a Director at Sun Pharma Advanced Research Company Limited (2017–2025) and Director at Medwell Ventures Private Limited (2014–2023) and 5 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Cytecare Hospitals Private Limited U85110GJ2014PTC079078 | Director | 15 Jun 2014 | 2014 | ₹93.10 Cr (FY 2024) | Active |
 Cytespace Research Private Limited U73100GJ2011PTC064350 | Director | 01 Apr 2014 | 2011 | ₹93 Lakh (FY 2025) | Active |
 Emergene Ai Private Limited U62010KA2026PTC222737 | Director | 20 Jun 2026 | 2026 | Active | |
| Bio-Combinator Llp ACF-9022 | Designated Partner | 06 Mar 2024 | 2024 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Sun Pharma Advanced Research Company Limited L73100GJ2006PLC047837 | Director | 05 May 2017 | 2006 | ₹73.56 Cr (FY 2025) | Active |
 Medwell Ventures Private Limited U85100DL2014PTC429322 | Director | 02 Jun 2014 | 2014 | ₹73.62 Cr (FY 2023) | Active |
 Cenduit (India) Services Private Limited U72200KA2007PTC042174 | Director | 05 Nov 2009 | 2007 | ₹74.87 Cr (FY 2021) | Amalgamated |
 Quintiles Data Processing Centre (India) Private Limited U72300GJ2001PTC040151 | Director | 25 Oct 2001 | 2001 | Amalgamated | |
 Iqvia Rds (India) Private Limited U74909KA2002PTC107115 | Director | 21 Nov 2002 | 2002 | ₹3,342 Cr (FY 2025) | Active |
 Quintiles Phase One Clinical Trials India Private Limited U73100TG2009FTC064239 | Director | 03 Jul 2009 | 2009 | ₹4.16 Cr (FY 2020) | Dissolved (Liquidated) |
| Triclinium Clinical Development Private Limited U74900GJ2016PTC091683 | Director | 26 Apr 2016 | 2016 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Ferzaan Nariman Engineer
| Name | DIN | Company | Designation |
|---|---|---|---|
| Mohan Vamsy Chigurupati | 02991799 | Cytecare Hospitals Private Limited | Additional Director |
| Padmaja Chigurupati | 03019601 | Cytecare Hospitals Private Limited | Additional Director |
| Gerardus Adrianus Hoogland | 06673807 | Cytespace Research Private Limited | Director |
| Gillian Margaret Morrow Corken | 06940674 | Cytespace Research Private Limited | Director |
| Himanshu Madhusudan Shah | 00025793 | Cytespace Research Private Limited | Director |
| Oppel Bernhardt Wilhelm Greeff | 07252369 | Cytespace Research Private Limited | Director |
| Suresh Ramu | 00240963 | Cytespace Research Private Limited | Director |
| Het Jogin Desai | 11781835 | Emergene Ai Private Limited | Director |
| Ashok Nana Vohra | 01186182 | Bio-Combinator Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ferzaan Nariman Engineer
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ferzaan Nariman Engineer
Ferzaan Nariman Engineer currently holds 4 directorships: Cytecare Hospitals Private Limited (Director, since 15 Jun 2014, revenue ₹93.10 Cr (FY 2024)); Cytespace Research Private Limited (Director, since 01 Apr 2014, revenue ₹93 Lakh (FY 2025)); Emergene Ai Private Limited (Director, since 20 Jun 2026); Bio-Combinator Llp (Designated Partner, since 06 Mar 2024).
Ferzaan Nariman Engineer was first appointed on 25 Oct 2001 as Director at Quintiles Data Processing Centre (India) Private Limited. The most recent appointment on record is 20 Jun 2026 at Emergene Ai Private Limited.
The 2 current companies of Ferzaan Nariman Engineer that report revenue have a combined latest revenue of ₹94.03 Cr: Cytecare Hospitals Private Limited ₹93.10 Cr (FY 2024); Cytespace Research Private Limited ₹93 Lakh (FY 2025).
Ferzaan Nariman Engineer held 7 earlier board appointments: Sun Pharma Advanced Research Company Limited (Director, 05 May 2017 to 12 Aug 2025); Medwell Ventures Private Limited (Director, 02 Jun 2014 to 19 Apr 2023); Cenduit (India) Services Private Limited (Director, 05 Nov 2009 to 20 Oct 2010); Quintiles Data Processing Centre (India) Private Limited (Director, 25 Oct 2001 to 01 Nov 2010); Iqvia Rds (India) Private Limited (Director, 21 Nov 2002 to 01 Jul 2009); and 2 more.
The current boards of Ferzaan Nariman Engineer's companies include Mohan Vamsy Chigurupati (Cytecare Hospitals Private Limited), Padmaja Chigurupati (Cytecare Hospitals Private Limited), Gerardus Adrianus Hoogland (Cytespace Research Private Limited), Gillian Margaret Morrow Corken (Cytespace Research Private Limited), Himanshu Madhusudan Shah (Cytespace Research Private Limited), Oppel Bernhardt Wilhelm Greeff (Cytespace Research Private Limited), among others.